%0 Journal Article
%T Development and psychometric properties of a five-language multiperspective instrument to assess clinical decision making style in the treatment of people with severe mental illness (CDMS)
%A Bernd Puschner
%A Petra Neumann
%A Harriet Jordan
%A Mike Slade
%A Andrea Fiorillo
%A Domenico Giacco
%A Anik¨® ¨¦gerh¨¢zi
%A Tibor Iv¨¢nka
%A Malene Krogsgaard Bording
%A Helle £¿stermark S£¿rensen
%A Arlette B£¿r
%A Wolfram Kawohl
%A Sabine Loos
%A 
%A for the CEDAR study group
%J BMC Psychiatry
%D 2013
%I BioMed Central
%R 10.1186/1471-244x-13-48
%X A participatory approach was chosen for instrument development which followed 10 sequential steps proposed in a current guideline of good practice for the translation and cultural adaptation of measures. Following item analysis, reliability, validity, and long-term stability of the CDMS were examined using Spearman correlations in a sample of 588 people with severe mental illness and 213 mental health professionals in 6 European countries (Germany, UK, Italy, Denmark, Hungary, and Switzerland).In both patient and staff versions, the two CDMS subscales ¡°Participation in Decision Making¡± and ¡°Information¡± reliably measure distinct characteristics of decision making. Validity could be demonstrated to some extent, but needs further investigation.Together with two other five-language patient- and staff-rated measures developed in the CEDAR study (ISRCTN75841675) ¨C ¡°Clinical Decision Making in Routine Care¡± and ¡°Clinical Decision Making Involvement and Satisfaction¡± ¨C the CDMS allows empirical investigation of the complex relation between clinical decision making and outcome in the treatment of people with severe mental illness across Europe.Decision-making in health care has been conceptualized as a process taking place between patient and health professional on a continuum between ¡°paternalistic¡±, ¡°shared¡±, and ¡°informed¡± [1,2]. Shared decision making has received much attention in research and practice since its first mention 30 years ago [3]. Substantial evidence has accumulated in recent decades for clinical decision making in acute (e.g. heart attack, stroke) and long-term physical conditions (e.g. cancer and fibromyalgia) [4-10]. Shared decision making has been termed an ethical imperative [11] and is recommended in guidelines for the treatment of people with schizophrenia [12].However, knowledge about clinical decision making in the treatment of people with mental illness is still limited. Most importantly, apart from a few studies [13], little is known about the
%U http://www.biomedcentral.com/1471-244X/13/48